Protagonist Therapeutics, Inc. (PTGX)
$143.73+2.73%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $9.2B
- Beta
- 1.79
- P/E (TTM)
- 113.86
- Short % float
- 17.80%
- Days to cover
- 11.5
- SI change
- +14.8%
- 1W
- +2.62%
- 1M
- -0.99%
- vs SPY 1W
- +1.46%
- vs SPY 1M
- -3.98%
Industry peers
FMP comparable companies · ranked by market cap
- SYRESELLSpyre Therapeutics, Inc.$7.0BCRISISQ 10$80.11+7.25%
- IMVTSELLImmunovant, Inc.$6.6BCRISISQ 25$32.11+0.69%
- IRONSELLDisc Medicine, Inc.$2.4BCRISISQ 1$61.65+2.12%
- ANABSELLAnaptysBio, Inc.$1.4BCRISISQ 25$47.89-0.56%
- ODTXSELLOdyssey Therapeutics, Inc.$871MQ 38$18.13+4.86%
- ACRSSELLAclaris Therapeutics, Inc.$517MCRISISQ 9$3.70+1.06%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
